Schmidt, E., Lister, J., Neumann, M., Wiecek, W., Fu, S., Vataire, A., . . . Marteau, F. (2018). Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: A Systematic Review and Network Meta-Analysis. Target Oncol.
استشهاد بنمط شيكاغوSchmidt, Elvira, Johanna Lister, Monika Neumann, Witold Wiecek, Shuai Fu, Anne-Lise Vataire, Jelena Sostar, Shengnan Huang, و Florence Marteau. "Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: A Systematic Review and Network Meta-Analysis." Target Oncol 2018.
MLA استشهادSchmidt, Elvira, et al. "Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: A Systematic Review and Network Meta-Analysis." Target Oncol 2018.